FDA Approval Could Skyrocket this Stock 🚨

This tiny stock could be on course for a major breakout after a recent FDA decision... Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Friday! It's June 23rd. I hope you have a great day in the market. Let's get ready to trade! Markets 📈 Stocks closed with mixed results on Thursday. The S&P 500 gained 0.3%, and the Nasdaq added 0.9%. The Dow closed just below flat with a small gain of less than 0.1%, and the small-cap Russell 2K tumbled 0.8%. Futures are down once again in early trading. S&P 500 contracts are down by more than 0.4%. Sponsored [FDA Approval Could Skyrocket this Stock]( 🚨 The FDA recently approved the sale of cell-cultivated meat for the first time in US history... And, one overlooked stock could be an ideal position to benefit from the FDA decision. Since the FDA green light, the sector is beginning to attract significant new capital and interest from "Smart Money" investors. This North American company plans to roll out a product within the next few months, and it could be a massive catalyst for the tiny stock [Get the Ticker Here & Make Your Move Now]( Premarket Highlights 🔎 📈 Bonds Rally; Stocks Fall After Rate Hikes Several prominent central banks have announced significant rate hikes in the past two weeks, and the Federal Reserve is already signalling it will raise rates again in July. The realization that rate hikes are here to stay likely played a significant role in the stock market's poor performance this week, but bonds have benefited from the sentiment shift. Yields on the 10-year U.S. Treasury bond fell from 3.797% to 3.743% overnight. What to Watch Today 👀 U.S. PMIs New data on the Purchasing Manager's Index comes out at 9:15 a.m. ET. The release will include flash data on both the manufacturing and services sections of the economy. Keep an eye on it because it could have an influence on investor sentiment, especially with rate hikes in focus. Major Earnings 💰 Carmax Inc [KMX] ... AM Apogee Enterprises, Inc. [APOG] ... AM Economy 🏗 S&P flash U.S. services PMI [Jun] ... 8:30a S&P flash U.S. manufacturing PMI [Jun] ... 8:30a Running Hot 🔥 Gainers - OncoSec [ONCS] >> +109.0% - Surgalign [SRGA] >> +78.6% - Castellum [CTM] >> +64.4% - Taylor Morn Home [TMHC] >> +26.8% Decliners - Spark Networks [LOV] >> (34.7%) - Ault Alliance [AULT] >> (15.8%) - SMX Security Matters [SMX] >> (25.5%) - Virgin Galactic [SPCE] >> (12.0%) CarMax [KMX] - Last Close: $78.32 A strong earnings report is boosting shares of CarMax. The auto retailer reported its fiscal Q1 earnings early Friday, and the results topped expectations. CarMax earned $1.44 per share in its fiscal Q1, down from $1.56 a year earlier, but better than the Street's $0.83 target. Revenues also fell by 17% to $7.69 billion for the quarter, which also beat the consensus of $7.52 billion. However, CarMax's comp sales fell by (-11.4%), exceeding investors' (-10.8%) forecast. KMX is this morning's top S&P 500 stock with a 6.1% gain. My Take: KMX has performed surprisingly well this year, but it's facing stiff resistance at $80 per share. It will be interesting to see if the stock can hold onto its gains. ConforMIS [CFMS] - Last Close: $1.16 ConforMIS is rallying after announcing a buyout deal. The MedTech company has agreed to be acquired by privately-held personalized 3d-printed orthopedic company restor3d in an all-cash deal. restor3d will pay $2.27 per share to acquire the company, a 95% premium to CFMS's Thursday closing price. ConfirMIS' board of directors has already voted unanimously to approve the measure, and the companies expect to close the deal sometime in Q3. CFMS is up 90.5% on news of the lucrative buyout deal. My Take: CFMS hit the ball out of the park on this one, but I am not sure if there's a lot of upside left in the stock at this point. A strategically-timed options trade could be worth exploring if prices remain below the acquisition bid. Nuvve [NVVE] - Last Close: $0.4553 A big announcement is boosting shares of Nuvve Holdings. The green energy tech firm announced the launch of its Astrea AI technology to optimize revenues for Nordic transmission system & V2G fleet customers. The AI continuously forecasts prices and capacity for Nordic primary reserves to optimize energy market bids. Astrea AI forecasts have shown 97% accuracy and help to maximize revenues with the right bid matched to available fleet capacity. CEO Gregory Poilasne said the AI "makes energy markets easier and more accurate to predict, enabling us to further optimize revenue..." NVVE is trading actively with a 53.7% gain in today's premarket. My Take: Another AI buzzword rally, but who knows if Astrea AI will live up to the hype? NVVE also has a 6.83% short rate, which could be accelerating today's rally. Rail Vision [RVSN] - Last Close: $0.5896 Rail Vision is rebounding after securing a multimillion-dollar cash injection. After Wednesday's close, the railway systems firm announced the closing of a $3 million private placement with its largest shareholder. Rail Vision said it issued almost 3.95 million ordinary shares and the same number of five-year warrants exercisable at $0.84 per share. The purchase price of one share and one warrant was $0.76, and the aggregate gross proceeds from this placement were $3 million. Shares of RVSN fell on Thursday following the release of the news, but they're rebounding in today's premarket. RVSN is up 13.3% in early trading. My Take: CFMS hit the ball out of the park on this one, but I am not sure if there's a lot of upside left in the stock at this point. A strategically-timed options trade could be worth exploring if prices remain below the acquisition bid. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](